476
Views
30
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Kinetic method for assaying the halogenating activity of myeloperoxidase based on reaction of celestine blue B with taurine halogenamines

, , , , , , , & show all
Pages 777-789 | Received 29 Sep 2014, Accepted 06 Feb 2015, Published online: 20 Mar 2015
 

Abstract

Myeloperoxidase (MPO) is a challenging molecular target which, if put under control, may allow regulating the development of inflammatory reactions associated with oxidative/halogenative stress. In this paper, a new kinetic method for assaying the halogenating activity of MPO is described. The method is based on measuring the rate of iodide-catalyzed oxidation of celestine blue B (CB) by oxygen and taurine N-chloramine (bromamine). The latter is produced in a reaction of taurine with HOCl (HOBr). CB is not a substrate for the peroxidase activity of MPO and does not react with hydrogen peroxide and superoxide anion radical. Taurine N-chloramine (bromamine) reacts with CB in molar ratio of 1:2. Using the new method, we studied the dependence of MPO activity on concentration of substrates and inhibitors. The specificity of MPO inhibition by non-proteolyzed ceruloplasmin is characterized. The inhibition of taurine N-chloramine production by neutrophils and HL-60 cells in the presence of MPO-affecting substances is demonstrated. The new method allows determining the kinetic parameters of MPO halogenating activity and studying its inhibition by various substances, as well as screening for potential inhibitors of the enzyme.

Acknowledgments

The authors are grateful to Professor V. N. Kokryakov (Institute of Experimental Medicine, St. Petersburg) for granted materials, valuable advice, and constructive discussions; to Professor A.A. Karyakin and Ph.D. A.V. Borisova (“RUSENS”) for granted H2O2-sensors. Estimation of rate constants was done with kind assistance of Dr. A.V. Bulatov (Department of Analytical Chemistry, Faculty of Chemistry, Saint-Petersburg State University). This study was supported by RFBR grants No. 13-04-01186, 14-04-00807, 14-04-90007, and 15-04-03620, and by the RAMS Program “Human Proteome”.

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.